Agenus to Host First 2026 Stakeholder Webcast on BOT+BAL Global Momentum
ByAinvest
Tuesday, Jan 20, 2026 6:29 pm ET1min read
AGEN--
Agenus will host a webcast on January 28, 2026, to discuss the momentum of its BOT+BAL global program entering 2026. The session will highlight the expansion of global access pathways, strategic partnerships, and operational readiness. Topics will include the recently closed strategic collaboration with Zydus Lifesciences, clinical perspective on BOT+BAL in sarcoma, and supporting access and readiness through global medical affairs. Agenus leadership and a leading international oncology expert will participate in the session, which will conclude with a live Q&A.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet